Spinal muscular atrophy: open trials in Germany

• NCT07900672

  Register for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System Disorders

  Research · Ambulanzpartner Soziotechnologie APST GmbH

  Charité - Universitätsmedizin Berlin; Charité Centrum für Neurologie, Neurochirurgie und Psychiatrie; Ambulanz für ALS, SMA und andere Motoneuronerkrankungen, Berlin

  Registry updated 2026-10-28

• NCT07221669

  A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

  Trial Treatment · Phase 3 · Biogen

  Universitaetsklinikum Essen (AoR), Essen · Universitaetsklinikum Heidelberg AöR, Heidelberg · Universitaetsklinikum Ulm AoR, Ulm

  Registry updated 2026-10-23

• NCT07444450

  A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

  Trial Treatment · Phase 3 · Biogen

  Article 11 CTR DE, DO NOT EDIT

  Registry updated 2026-10-15

• NCT06555419

  A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)

  Trial Treatment · Phase 1 · Biogen

  Universitaetsklinikum Essen (AoR), Essen · Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), Munich

  Registry updated 2026-09-03

• NCT05866419

  Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

  Trial Treatment · Alcyone Therapeutics, Inc

  Universitätsklinikum Essen, Essen

  Registry updated 2026-08-19

• NCT06605612

  Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

  Research · LMU Klinikum

  Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München, München

  Registry updated 2025-09-10

• NCT07072676

  The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

  Trial Treatment · LMU Klinikum

  Medical Park, Bad Feilnbach, Reithofpark, Bad Feilnbach

  Registry updated 2025-07-18

All Spinal muscular atrophy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error